Sign in
4

Changes in Ownership

Aclaris Therapeutics, Inc. Filed Acc 0001209191-15-086742

Options or other derivatives

  • Director acquired 2,759 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Molineaux Christopher P. Director 2015-12-18 Grant or award · Stock option (right to buy) +2,759 2,759 D: show line 1 in the form
Loading xslF345X03/doc4.xml…